v3.26.3
Cash, Cash Equivalents, and Financial Instruments
9 Months Ended
Sep. 30, 2026
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents, and Financial Instruments

Note 3 – Cash, Cash Equivalents, and Financial Instruments

 

The following table shows the Company’s cash, cash equivalents, and marketable investment securities by significant investment category:

 

   September 30, 2026 
   Adjusted Cost   Total Unrealized Gains / (Losses)   Fair Value   Cash and Cash Equivalents   Marketable Investment Securities 
Cash  $714,803   $-   $714,803   $714,803   $- 
Total  $714,803   $       -   $714,803   $714,803   $        - 

 

   December 31, 2025 
   Adjusted Cost   Total Unrealized
Gains / (Losses)
   Fair Value   Cash and Cash Equivalents   Marketable Investment Securities 
Cash  $11,884,607   $-   $11,884,607   $11,884,607   $- 
Total  $11,884,607   $     -   $11,884,607   $11,884,607   $       -